Insights

Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is implicated in tumor growth and progression. Understanding CPEB4

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is an RNA-binding protein involved in mRNA processing.
  • CPEB4 regulates cytoplasmic polyadenylation and translation, crucial for gene expression.
  • Abnormal CPEB4 expression is observed in various human tumors and correlates with patient prognosis.

Purpose of the Study:

  • To elucidate the relationship between CPEB4 and malignant tumors.
  • To understand the molecular mechanisms by which CPEB4 regulates tumorigenesis.
  • To explore CPEB4 as a potential target for cancer diagnosis and therapy.

Main Methods:

  • Literature review of current research on CPEB4 in cancer.
  • Analysis of studies investigating CPEB4 expression patterns in tumors.
  • Examination of molecular pathways involving CPEB4 in tumor development.

Main Results:

  • CPEB4 plays a significant role in tumor cell proliferation, migration, invasion, and epithelial-mesenchymal transition.
  • Aberrant CPEB4 expression is a common feature across multiple cancer types.
  • Correlation between abnormal CPEB4 levels and poor prognosis in cancer patients.

Conclusions:

  • CPEB4 is a key regulator in malignant tumor development and progression.
  • Targeting CPEB4 may offer new avenues for cancer molecular diagnosis and therapy.
  • Further research into CPEB4's mechanisms can advance cancer treatment strategies.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K